Concept Award – HT-9425-23-LCRP-CA – Letter of Intent due 2 May 3023
- up to USD$100,000 over 1 year
- supports highly innovative, untested, potentially ground breaking concepts in lung cancer
- emphasis on innovative concept or untested theory
- clinical trials not allowed
- preliminary data not required
- relevance to military health strongly encouraged
Idea Development Award – HT9425-23-LCRP-IDA – Letter of Intent due 10 May 2023
- up to USD$525,000 over 3 years
- Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research.
- Emphasis is on innovation and impact.
- ECR and established investigator options
- clinical trials not allowed
- preliminary data not required
- relevance to military health strongly encouraged
Translational Research Award – HT9425-23-LCRP-TRA – Preproposals due 10 May 2023
- Level 1 – up to USD$900,000 over 3 years
- Level 2 Clinical Trial Option – up to USD$1.2M over 4 years
- Supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications.
- preliminary lung cancer relevant data required
- relevance to military health is strongly encouraged
Career Development Award – HT9425-23-LCRP-CDA – Letter of Intent due 2 May 2023
- up to USD$375,000 over 3 years
- Supports early-career, independent researchers to conduct research under the mentorship of an experienced lung cancer researcher.
- Emphasis on research with high potential impact.
- Clinical trials not allowed.
- Career development plan is required with appropriate mentor guidance.
- Preliminary data not required.
- Relevance to military health is strongly encouraged
